BackPoseida Therapeutics Overview

Poseida Therapeutics Total Assets

Poseida Therapeutics's total assets is $290M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$293.58M
↓ 2.87% YoYΔ $-8.68M vs prior year quarter

Peer trimmed avg / median

Loading

Poseida Therapeutics Total Assets History

Loading

Poseida Therapeutics vs. peers: Total Assets Comparison

Loading

Poseida Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Poseida Therapeutics (PSTX) FAQ

As of the most recent data (September 2024), PSTX shows a total assets of $290M. That compares with $300M in the prior-year period — down 2.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PSTX's total assets is now $290M (was $300M) — a 2.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Poseida Therapeutics is outperforming or lagging.

Tracking PSTX's total assets over time shows whether Poseida Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $290M That compares with $300M in the prior-year period — down 2.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Poseida Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $290M) with ownership activity and broader fundamentals.

Poseida Therapeutics's total assets is $290M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.